These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1196 related items for PubMed ID: 18389322

  • 1. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M.
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [Abstract] [Full Text] [Related]

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 3. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ, Liu MC, Jian JJ, Horng CF, Cheng TI, Chen CM, Fang WT, Chung YL.
    Ann Surg Oncol; 2007 Oct 15; 14(10):2766-72. PubMed ID: 17551794
    [Abstract] [Full Text] [Related]

  • 4. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG.
    Ann Surg; 2008 Aug 15; 248(2):243-51. PubMed ID: 18650634
    [Abstract] [Full Text] [Related]

  • 5. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
    Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR.
    Cancer; 2008 Jul 01; 113(1):57-64. PubMed ID: 18442099
    [Abstract] [Full Text] [Related]

  • 6. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome?
    Habr-Gama A, Perez RO, Proscurshim I, Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J, Cecconello I.
    Int J Radiat Oncol Biol Phys; 2008 Jul 15; 71(4):1181-8. PubMed ID: 18234443
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, Coco C, Romano M, Mantello G, Palazzi S, Mattia FO, Friso ML, Genovesi D, Vidali C, Gambacorta MA, Buffoli A, Lupattelli M, Favretto MS, La Torre G.
    Int J Radiat Oncol Biol Phys; 2008 Sep 01; 72(1):99-107. PubMed ID: 18407433
    [Abstract] [Full Text] [Related]

  • 8. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K.
    Ann Surg Oncol; 2008 Dec 01; 15(12):3471-7. PubMed ID: 18846402
    [Abstract] [Full Text] [Related]

  • 9. Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer.
    Katz MS, Minsky BD, Saltz LB, Riedel E, Chessin DB, Guillem JG.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1363-70. PubMed ID: 16029794
    [Abstract] [Full Text] [Related]

  • 10. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
    Wolthuis AM, Penninckx F, Haustermans K, De Hertogh G, Fieuws S, Van Cutsem E, D'Hoore A.
    Ann Surg Oncol; 2012 Sep 01; 19(9):2833-41. PubMed ID: 22451236
    [Abstract] [Full Text] [Related]

  • 11. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W, Boterberg T, Pattyn P, van Eijkeren M, Gillardin JM, Demetter P, Smeets P, Van Damme N, Monsaert E, Peeters M.
    Ann Surg Oncol; 2007 Feb 01; 14(2):424-31. PubMed ID: 17096057
    [Abstract] [Full Text] [Related]

  • 12. Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII rectal cancers.
    de Campos-Lobato LF, Stocchi L, da Luz Moreira A, Kalady MF, Geisler D, Dietz D, Lavery IC, Remzi FH, Fazio VW.
    Ann Surg Oncol; 2010 Jul 01; 17(7):1758-66. PubMed ID: 20131015
    [Abstract] [Full Text] [Related]

  • 13. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ, Zager JS, Chang GJ, Feig BW, Wood CG, Skibber JM, Rodriguez-Bigas MA.
    Ann Surg Oncol; 2007 Jun 01; 14(6):1870-7. PubMed ID: 17406945
    [Abstract] [Full Text] [Related]

  • 14. [Local tumor control and (disease-free) survival after surgery with pre- and intraoperative radiotherapy for primary non-resectable rectal carcinoma and local recurrence].
    Mannaerts GH, Martijn H, Rutten HJ, Hanssens PE, Wiggers T.
    Ned Tijdschr Geneeskd; 2001 Jul 28; 145(30):1460-6. PubMed ID: 11503316
    [Abstract] [Full Text] [Related]

  • 15. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J, Vera R, Balén E, Gómez M, Arias F, Lera JM, Herrera J, Zazpe C.
    Colorectal Dis; 2008 Jul 28; 10(6):563-8. PubMed ID: 18070184
    [Abstract] [Full Text] [Related]

  • 16. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A, Mukhopadhyay T, Ramani VS, Perkins K, Snee AJ, Jelley F, Wong H, Lee CD.
    Colorectal Dis; 2010 Aug 28; 12 Suppl 2():30-6. PubMed ID: 20618365
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer].
    Yu BM, Zhang M, Wu WQ, Chen LW, Fu J, Fei CS, Shen Y.
    Zhonghua Wai Ke Za Zhi; 2007 Apr 01; 45(7):445-8. PubMed ID: 17686297
    [Abstract] [Full Text] [Related]

  • 18. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD, Gaur P, Force SD, Staley CA, Mansour KA, Miller JI, Miller DL.
    Ann Thorac Surg; 2008 Apr 01; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
    Wu B, Qiu HZ, Xiao Y, Lin GL, Niu BZ, Zhang FQ, Hu K.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar 01; 11(2):124-7. PubMed ID: 18344077
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.